Q3 sales align with expectations, guidance for 2025 reaffirmed
30/10/25 -"Haleon’s Q3 sales aligned with expectations, driven by growth in Oral Health, VMS, Pain Relief, and Digestive Health. This was partially offset by weaknesses in Respiratory Health and ..."
Pages
56
Language
English
Published on
30/10/25
You may also be interested by these reports :
03/11/25
Puig delivered an impressive Q3 25, beating expectations with extraordinary momentum in makeup and solid progress in Asia. The group raised its FY25 ...
30/10/25
Haleon’s Q3 sales aligned with expectations, driven by growth in Oral Health, VMS, Pain Relief, and Digestive Health. This was partially offset by ...
30/10/25
Essity delivered a profit beat for Q3 2025, with an Adj. EBITA of SEK 5,056m and an impressive 14.6% margin, exceeding consensus despite in-line net ...
29/10/25
Reckitt delivered estimate-beating Q3 2025 sales of £3.61bn, up a robust 7.0%, driven by sequential volume improvements and solid emerging markets ...